Editorials Open access

The 2023 hypertension guidelines of the European Society of Hypertension: a commentary

Authors

Published
19 December 2023
Section
Editorials
DOI
10.4081/itjm.2023.1675

Abstract

The 2023 hypertension guidelines of the European Society of Hypertension (ESH) have been published in the December issue of the official Journal of the Society (Journal of Hypertension),1 where they are freely available online. Compared to the guidelines published 5 years ago,2 the new guidelines address issues never or only marginally addressed before, including a large number of comorbidities to hypertension that may change the approach to antihypertensive management. [...]

Keywords

References

  1. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH guidelines for the management of arterial hypertension. J Hypertens 2023;41:1874-2071. DOI: https://doi.org/10.1097/HJH.0000000000003480
  2. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018;36:1953-2041. DOI: https://doi.org/10.1097/HJH.0000000000001940
  3. Corrao G, Mancia G. Research strategies in treatment of hypertension: value of retrospective real-life data. Eur Heart J 2022;43:3312-22. DOI: https://doi.org/10.1093/eurheartj/ehab899
  4. SCORE 2 Working group and ESC Cardiovascular Risk Collaboration. SCORE 2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular risk in Europe. Eur Heart J 2021;42:2439-54. DOI: https://doi.org/10.1093/eurheartj/ehab309
  5. Conroy RM, Pyorala K, Fitzgerald A, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003. DOI: https://doi.org/10.1016/S0195-668X(03)00114-3
  6. Ciardullo S, Monti T, Sala I, et al. Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories. Hypertension 2020;76:562-8. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.15220
  7. Mancia G, Bombelli M, Brambilla G, et al. Long-term prognostic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension 2013;62:168-74. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.111.00690
  8. Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010;31:883-91. DOI: https://doi.org/10.1093/eurheartj/ehp546
  9. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121-58. DOI: https://doi.org/10.1097/HJH.0b013e328333146d
  10. Mancia G. Evidence in favour of ambulatory blood pressure grows but gaps in knowledge remain. Lancet 2023;401:2014-5. DOI: https://doi.org/10.1016/S0140-6736(23)00442-7
  11. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:e13-e115. DOI: https://doi.org/10.1161/HYP.0000000000000075
  12. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering treatment in hypertension. J Hypertens 2016;34:1451-63. DOI: https://doi.org/10.1097/HJH.0000000000000972
  13. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 2020;75:1334-57. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
  14. Excellence. NIfHaC. National Institute for Health and Clinical Excellence. Hypertension (CG127): clinical management of primary hypertension in adults. Available from: www.nice.org.uk/guidance/CG127 and www.nice.org.uk/guidance/CG1272018.
  15. Mancia G, Zambon A, Soranna D, et al. Factors involved in the discontinuation of antihypertensive therapy: an analysis from real life data. J Hypertens 2014;32:1708-15. DOI: https://doi.org/10.1097/HJH.0000000000000222
  16. Rea F, Corrao G, Merlino L, et al. Initial antihypertensive treatment strategies and therapeutic inertia. Hypertension 2018;72:846-53. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.118.11308

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2023 the Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.